Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 Jan 28;12(2):132–137. doi: 10.1016/j.clml.2011.12.005

Table 1.

Characteristics of Patients With del(11q)/del(17p) CLL: Overall and by IGHV Mutation Percentagea

Characteristic All Patients N = 66 IGHV < 2% n = 50 IGHV ≥ 2% n = 16 P Value
Age at Diagnosis (Years), Median (Range) 57.6 (26.8, 81.2) 57.6 (26.9, 81.2) 56.5 (30.3, 78.4) 0.90
Stage at Diagnosis, No. (%)
    Rai 0 21 (33) 15 (31) 6 (38) < 0.99
    Rai 1 28 (44) 21 (44) 7 (44)
    Rai 2 10 (16) 8 (17) 2 (12)
    Rai 3 3 (5) 2 (4) 1 (6)
    Rai 4 2 (3) 2 (4) 0 (0)
    Unknown 2 2 0
Time from Diagnosis to Initial JHU Consultation (Years), Median (Range) 0.5 (0, 16.3) 0.6 (0, 13.0) 0.4 (0, 16.3) 0.539
Stage at Initial JHU Consultation, No. (%)
    Rai 0 20 (31) 12 (24) 8 (50) .062
    Rai 1 28 (43) 21 (43) 7 (44)
    Rai 2 5 (8) 5 (10) 0 (0)
    Rai 3 2 (3) 1 (2) 1 (6)
    Rai 4 10 (15) 10 (20) 0 (0)
    Richter transformation 0 (0) 0 (0) 0 (0)
    Unknown 1 1 0
Received Treatment Before JHU Consultation
    No 48 (73) 33 (66) 15 (94) .05
    Yes 18 (22) 17 (34) 1 (6)
Time from Diagnosis to FISH (Years) - Median (Range) 1.2 (0, 18.9) 1.9 (0, 13.2) 0.7 (0, 18.9) .26
Documented del(11q) - No. (%)
    No 27 (41) 22 (44) 5 (31) < .001
    Yes 39 (59) 28 (56) 11 (69)
Documented del(17p) - No. (%)
    No 39 (59) 28 (56) 11 (69) .40
    Yes 27 (41) 22 (44) 5 (31)

Abbreviations: IGHV = immunoglobulin heavy-chain variable; JHU = Johns Hopkins University.

a

P values for Fisher exact test or Wilcoxon rank sum tests for differences in variables between mutation groups.